Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petco Health & Wellness Company (WOOF) Depreciation & Amortization (CF) (2020 - 2026)

Petco Health & Wellness Company's Depreciation & Amortization (CF) history spans 7 years, with the latest figure at $48.2 million for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) fell 18.37% year-over-year to $48.2 million; the TTM value through Jan 2026 reached $196.7 million, down 5.66%, while the annual FY2026 figure was $196.7 million, 5.66% down from the prior year.
  • Depreciation & Amortization (CF) reached $48.2 million in Q1 2026 per WOOF's latest filing, down from $49.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $59.1 million in Q1 2025 to a low of $46.8 million in Q1 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $50.0 million, with a median of $49.4 million recorded in 2025.
  • Peak YoY movement for Depreciation & Amortization (CF): rose 17.86% in 2022, then decreased 18.37% in 2026.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $48.0 million in 2022, then grew by 5.51% to $50.7 million in 2023, then fell by 1.11% to $50.1 million in 2024, then decreased by 0.58% to $49.8 million in 2025, then dropped by 3.16% to $48.2 million in 2026.
  • Per Business Quant, the three most recent readings for WOOF's Depreciation & Amortization (CF) are $48.2 million (Q1 2026), $49.8 million (Q4 2025), and $49.3 million (Q3 2025).